111 related articles for article (PubMed ID: 22435555)
1. NF-κB and chromatin: ten years on the path from basic mechanisms to candidate drugs.
Natoli G
Immunol Rev; 2012 Mar; 246(1):183-92. PubMed ID: 22435555
[TBL] [Abstract][Full Text] [Related]
2. Tuning up inflammation: how DNA sequence and chromatin organization control the induction of inflammatory genes by NF-kappaB.
Natoli G
FEBS Lett; 2006 May; 580(12):2843-9. PubMed ID: 16530189
[TBL] [Abstract][Full Text] [Related]
3. It takes two to tango: IκBs, the multifunctional partners of NF-κB.
Hinz M; Arslan SÇ; Scheidereit C
Immunol Rev; 2012 Mar; 246(1):59-76. PubMed ID: 22435547
[TBL] [Abstract][Full Text] [Related]
4. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer.
Steger DJ; Workman JL
EMBO J; 1997 May; 16(9):2463-72. PubMed ID: 9171359
[TBL] [Abstract][Full Text] [Related]
5. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression.
Rahman I; Marwick J; Kirkham P
Biochem Pharmacol; 2004 Sep; 68(6):1255-67. PubMed ID: 15313424
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes.
Diatchenko L; Romanov S; Malinina I; Clarke J; Tchivilev I; Li X; Makarov SS
J Leukoc Biol; 2005 Dec; 78(6):1366-77. PubMed ID: 16204640
[TBL] [Abstract][Full Text] [Related]
7. Peroxide-mediated chromatin remodelling of a nuclear factor kappa B site in the mouse inducible nitric oxide synthase promoter.
Wei J; Guo H; Gao C; Kuo PC
Biochem J; 2004 Feb; 377(Pt 3):809-18. PubMed ID: 14599292
[TBL] [Abstract][Full Text] [Related]
8. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes.
Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R
Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370
[TBL] [Abstract][Full Text] [Related]
9. Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors.
Smale ST
Immunol Rev; 2012 Mar; 246(1):193-204. PubMed ID: 22435556
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of NF-kappaB by elongation factors is determined by core promoter type.
Amir-Zilberstein L; Ainbinder E; Toube L; Yamaguchi Y; Handa H; Dikstein R
Mol Cell Biol; 2007 Jul; 27(14):5246-59. PubMed ID: 17502349
[TBL] [Abstract][Full Text] [Related]
11. The mouse mammary tumour virus promoter positioned on a tetramer of histones H3 and H4 binds nuclear factor 1 and OTF1.
Spangenberg C; Eisfeld K; Stünkel W; Luger K; Flaus A; Richmond TJ; Truss M; Beato M
J Mol Biol; 1998 May; 278(4):725-39. PubMed ID: 9614938
[TBL] [Abstract][Full Text] [Related]
12. Lingual antimicrobial peptide and IL-8 expression are oppositely regulated by the antagonistic effects of NF-κB p65 and C/EBPβ in mammary epithelial cells.
Liu S; Shi X; Bauer I; Günther J; Seyfert HM
Mol Immunol; 2011 Mar; 48(6-7):895-908. PubMed ID: 21255844
[TBL] [Abstract][Full Text] [Related]
13. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
[TBL] [Abstract][Full Text] [Related]
14. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers.
Leung TH; Hoffmann A; Baltimore D
Cell; 2004 Aug; 118(4):453-64. PubMed ID: 15315758
[TBL] [Abstract][Full Text] [Related]
15. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
[TBL] [Abstract][Full Text] [Related]
17. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
Lee AH; Hong JH; Seo YS
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
[TBL] [Abstract][Full Text] [Related]
19. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
[TBL] [Abstract][Full Text] [Related]
20. An optimized extended DNA kappa B site that enhances plasmid DNA nuclear import and gene expression.
Gonçalves C; Ardourel MY; Decoville M; Breuzard G; Midoux P; Hartmann B; Pichon C
J Gene Med; 2009 May; 11(5):401-11. PubMed ID: 19326361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
